The actVl genetic region ofStreptomyces coelicolor A3(2) is part of the biosynthetic gene cluster of actinorhodin (ACT), the act cluster, consisting of six ORFs: ORFB, ORFA, ORF1, ORF2, ORF3, ORF4. A newly devised method of ACTdetection with a combination of HPLC and LC/MSwas applied to the analysis of the disruptants of each OREACTwas produced by those of ORFB, ORFA, ORF3, and ORF4. Instead of ACT, the ORF1disruptant produced 3,8-dihydroxy-l -methylanthraquinone-2-carboxylic acid (DMAC)and aloesaponarin II as shunt products. The ORF2 disruptant gave 4-dihydro-9-hydroxy-l -methyl-1 0-oxo-3-//-naphtho-[2,3- pp.144 -152
(Received for publication October 6, 1 999) The actVl genetic region ofStreptomyces coelicolor A3 (2) is part of the biosynthetic gene cluster of actinorhodin (ACT), the act cluster, consisting of six ORFs: ORFB, ORFA, ORF1, ORF2, ORF3, ORF4. A newly devised method of ACTdetection with a combination of HPLC and LC/MSwas applied to the analysis of the disruptants of each OREACTwas produced by those of ORFB, ORFA, ORF3, and ORF4. Instead of ACT, the ORF1disruptant produced 3,8-dihydroxy-l -methylanthraquinone-2-carboxylic acid (DMAC)and aloesaponarin II as shunt products. The ORF2 disruptant gave 4-dihydro-9-hydroxy-l -methyl-1 0-oxo-3-//-naphtho- [2,3- Actinorhodin1) (ACT, 1) produced by Streptomyces coelicolor A3(2) has a unique dimeric structure with connection of two benzoisochromanequinone (BIQ) chromophores by a C-C bond. Its pH indicator properties (red under acidic conditions and blue under basic ones) have provided a convenient method of ACT detection simply by blue pigmentation, resulting in the successful characterization2) of mutants in ACTbiosynthesis, followed by cloning3) of the whole biosynthetic gene cluster (the act cluster) from the S. coelicolor chromosome. The carbon skeleton of ACTis produced from a linear polyketide chain (an octaketide) condensed by a polyketide synthase (PKS) from an acetate starter unit with seven malonyl CoAs. pp.144 -152 Sequencing of the region of the act cluster4) encoding the PKS, and of homologous clusters from the producers of granaticin5) and tetracenomycin6), revealed the architecture of these enzymes as type II PKSs, with a minimal PKS78) consisting of three subunits: ketosynthase (KS), chain length factor (CLF), and acyl carrier protein (ACP). Besides the minimal PKSgenes, the act cluster, spanning over 22 kb, contains other genes encoding proteins relevant to ACT biosynthesis.
The early biosynthetic enzymes closely associated with the minimal PKS include a ketoreductase9) (KR, encoded by actlll) functioning at C-9, an aromatase4) (ARO, encoded by actWll) involved in aromatisation of the first ring by dehydration, and a Present address: School of Chemistry, University of Bristol, Cantock's Close, Bristol BS8 ITS, U.K. (' tailoring' ) steps10) to produce the final structure, involving a number of interesting biosynthetic problems. One of the key issues is formation of the third (pyran) ring, with stereochemical control to provide the (3S, 15R) configuration.
The actWl region, located near the left-end of the act cluster ( Figure 2 ), was deduced to be involved in pyran ring formation based on the fact that the two actVl mutants2) produce aloesaponarin II (3) as a shunt product11} ( Figure   1 ). DNAsequencing12) of the actVl region (5.7 kb) revealed six ORFs: ORFB, ORFA, ORF1, ORF2, ORF3, ORF4, and subsequent gene disruption of each ORFgave the following phenotypes in respect of pigmentation: (1) disruption of ORFB and ORF4 did not prevent blue pigmentation at apparently wild type levels; (2) the ORFA-disruptant showed an obvious reduction in blue pigmentation; (3) brownish pigment was produced by the disruptants of ORF1 and ORF2; (4) the ORF3-disruptant produced a reddish pigment which became yellowish and later turned 
Materials and Methods

Bacterial Strains and Culture Conditions
The ACT-producing S. coelicolor A3(2) strains were M14513) (SCP1~, SCP2~) and J150114) (hisAl uraAl strAl pgl SCP1~SCP2~). The gene disruptants ofactVl ORFs ir J1501 were obtained by insert-directed recombination15 using </>C3 1-derived KC51513) vectors carrying fragments internal to each ORFas described before12). Streptomyces strains and disruptants were grown using a modification oJ the method of reference 16. Seed cultures (10ml) were grown in 50ml culture tubes containing glucose 2%.
peptone (DIFCO) 0.3%, beef extract (DIFCO) 0.3%, yeasi extract (DIFCO) 0.1%, NaCl 0.3%, CaCO3 0.1%, pH 7.0: on a rotary shaker (220rpm) at 30°C for 2 days. Aliquots oi the culture were transferred to 50 ml of production medium (pH 7.0) consisting of glycerol 1.5%, soybean meal (Nissirj Soya Flour F-T) 1%, and NaCl 0.3% in 500ml Erlenmeyer flasks which were grown with shaking (200rpm) at 28°C for 4 days.
Isolation and Purification of Actinorhodin (ACT)
The mycelium of Ml45 cultures (2 litres) was harvested by centrifugation (l,700X#, 10 minutes), washed with 800 ml of 1n HC1, and stirred with 800ml of 1n NaOH. The solubilised blue pigment was separated from the mycelial residue by centrifugation (l,700Xg, 10 minutes). The supernatant was acidified to pH 3 with cone. HC1, producing a red precipitate of crude ACT.The precipitate was collected by centrifugation (l,700X#, 10 minutes), and washed with acetone (600ml) followed by filtration. The residual pigment was dried in vacuo and recrystallised from 1, 4-dioxane to give 233 mg of ACTas a reddish powder.
HPLCAnalysis of ACTfrom Streptomyces Mycelium
The mycelium from a 50-ml liquid culture was harvested by centrifugation (1,700X0, 10 minutes), washed twice with 20ml of In HC1 and with 20ml of deionised H2O, followed by lyophilization. The ground residue was extracted with 50 ml of 1 ,4-dioxane with shaking overnight. The mixture was centrifuged at 4,000Xg for 5 minutes, and the supernatant was subjected to reversed-phase HPLC analysis by monitoring the absorbance at 520nm using a Luna C18 (2 
Results and Discussion
The previous method for chemical characterisation of
ACTis based on its conversion to the dimethyl ester, then further to tetracetate17 18). This chemical derivatisation is made inefficient (overall yield is less than 10%) because of the chemical properties of ACT:it is almost insoluble in any standard organic solvent used for spectroscopic studies at neutral pH. 1,4-Dioxane was found to solubilise a reasonable amount of ACTfrom mycelium of S. coelicolor A3(2), allowing direct chracterisation of ACT. The highly conjugated chromophore of ACT gives an absorbance maximumin the visible region (520 nm), which turned out to be diagnostic for ACTdetection on HPLCanalysis. The peak corresponding to ACT detected by monitoring at 520nmwas evaluated by LC/MSanalysis under the same chromatographic conditions used for HPLC (Figure 3 ). It gave a protonated molecular ion of ACT (C32H26O14) at m/z 635, indicating the reliability of this method. The HPLC method was applied to the chemotype analysis of the gene disruptants of the actVl region of S. coelicolor A3 (2) . ACTwas detected from the disruptants of ORFB, ORFA, ORF3, and ORF4, whereas the disruptants ofORF1 and ORF2were found to be ACTnonproducers. This is consistent with the previous phenotypic 147 observation12) based on blue pigmentation alone. The culture mediumof the disruptants was also analysed by reversed-phase HPLC (Figure 4 ). The ORFl-disruptant produced 3 , 8-dihydroxy-1 -methylanthraquinone-2-carboxylic acid (DMAC, 8) and aloesaponarin II (3) as shunt products.
This result agrees with the fact that the actVI mutants2) mentioned earlier were mapped12) to ORF1 by complementation. The culture mediumof the disruptant of ORF2 was more yellowish compared with the other disruptants, and it produced 4-dihydro-9-hydroxy-l -methyl- caused significant reduction in ACTproduction, suggesting that they encode proteins possibly catalysing ACT biosynthetic steps that otherwise proceed spontaneously (see below). The result on the ORF4disruptant contradicts our earlier observation that it gave blue pigmentation on agar mediumat an apparently wild type level, and indicates the importance of quantifying ACT production in the present study. Disruption of ORFBgave comparable ACT productivity to the wild type, J1501. Apparently, this gene is not directly relevant to ACT biosynthesis, possibly being outside of the act cluster.
Significant similarity between the acfVI-ORFl protein and /3-hydroxyacyl CoA dehydrogenases (HACD) belonging to a family of short-chain alcohol dehydrogenases led us to propose12^( Figure 5 ) that the partial structure (a) of (2) can be recognised as the substrate motif of HACD: the artVI-ORFl protein would reduce the keto-group at C-3 to give the chiral secondary alcohol (4), which would cyclise to the hemiketal (5), followed by dehydration to afford (S)-DNPA (6). This hypothesis was proved20) when (6) was produced by S. coelicolor CH999,21) a host strain deleted for the act cluster, carrying the recombinant plasmid, pIJ5660; this carries the act minimal PKS, KR, AROand CYC, together with artVI-ORF 1. Chemically spontaneous formation of the hemiketal (5) and its dehydration might be enzymatically assisted for efficient pyran ring formation. Such potential assisting proteins could be encoded by actVI-OKF3 and -ORFA, as indicated by the phenotypes of the corresponding disruptants: disruption of ORF3 resulted in delayed pigmentation on ammonia fuming; and the ORFAdisruptant gave lower productivity of ACTcompared with the wild type strain.
Of the two genes, ac^VI-ORFAhas known homologues in the biosynthetic gene clusters for five other actinomycete aromatic polyketides: granaticin (gra-ORF3 1 22)), frenolicin (frenX23^), mithramycin (mtrnX24^), doxorubicin/daunorubicin (dpsR25); dauZ26)), and an unknown compound (ORF127)).
In no example has its role been definitively deduced. Gerlitz et al. suggested25) that dpsH might encode some kind ofpolyketide cyclase, based on its ability to favour formation of a tricyclic intermediate of (a) HPLCchromatograms of the metabolites from culture mediumof S. coelicolor J150land its disruptants of actVI- ORF 1, 2, and A. (b) UV/VIS spectra of the peaks corresponding to DMAC, (S)-DNPA, and compound X as indicated by arrows.
doxorubicin biosynthesis rather than a monocyclic shunt product, but this was not confirmed in later work28).
However,because of the presence of such genes in gene clusters for the biosynthesis of compounds that contain exclusively carbocyclic, not pyran ring systems, they are more likely to play a general role in stabilising the multicomponent, type II PKS complex, rather than in catalysing pyran ring formation itself. This possibility agrees with the present results that the disruption of
ORFAdid not abolish ACTproduction, but resulted in accumulation of possible biosynthetic intermediates, leading to gross reduction in ACTbiosynthesis. In contrast, the only homologue of actVl-ORF3 so far discovered22) in a complete biosynthetic gene cluster (or elsewhere) is in the granaticin cluster (ORF18), and granaticin, like actinorhodin, contains a pyran ring as part of the BIQ structure. ORF3 is therefore the most likely candidate to facilitate the closure of the pyran ring of actinorhodin, which is presumed to be capable of spontaneous chemical closure in the absence of this gene22). The hemiketal (5) was not detected from any disruptant described here under the present analytical conditions. Perhaps it was too unstable to be chemically characterised as in the case of the production of (S)-DNPA by CH999 carrying pIJ5660, mentioned earlier.
Based on the similarity of the partial structure (b) ( Figure 5 ) of (6) with the substrate motif of enoyl reductases, with which the products of ORF2and ORF4are homologous, we proposed12) that (6) would undergo stereospecific reduction at C-15 by the ORF2protein with 1 ,4-reduction to facilitate (7) with the correct configuration found in ACT.This reduction might proceed in two coupled steps, with reduction of the double bond between C-14 and C-15 followed by isomerisation to afford the a,punsaturated carbonyl structure of (6) . Despite the mutual similarity (52%) of ORF2 and ORF4, the ORF4 disruptant did produce ACT in substantially less quantity than the wild-type without accumulation of (iS')-DNPA, favouring the idea that the ORF2 protein would function as the essential reductase at C-15, with the ORF4 product assisting in the chemically favoured isomerisation. Taken together with the fact that the ORF2disruptant produced (6), which is a postulated substrate for a probable reductase encoded by ORF2, the results strongly reinforce the proposed biosynthetic scheme.
